Your browser doesn't support javascript.
loading
Comparison of Approval Process for Nonprescription Drugs in Different Countries
Korean Journal of Clinical Pharmacy ; : 263-272, 2018.
Article in Korean | WPRIM | ID: wpr-718452
ABSTRACT
Nonprescription drugs have become increasingly important in Korean healthcare. By leveraging lower-cost drugs and reducing expenditure associated with fewer physician visits, the nonprescription segment can deliver tremendous value to individual consumers and the Korean healthcare system. Many countries have provided simpler and more rapid routes to market entry for qualifying nonprescription drug products, using the established data on drug safety and efficacy, as well as public and professional opinion. In US, the FDA waived the pre-approval process for over-the-counter (OTC) drugs marketed through the OTC Monograph Process. In Australia and Canada, different OTC product application levels are defined, with a reduced level of assessment required when the risks to consumers are considered low. Japan established a new OTC evaluation system in 2014 to facilitate the Rx-to-OTC switch process. The legislative framework for medicinal products in the European Union allows for drugs to be approved with reference to appropriate bibliographic data for old active substances with well-established uses. Through a comparison of the regulatory framework and the requirements for nonprescription approval process in different countries, several ways to improve regulatory practice for the evaluation of nonprescription drugs in Korea have been suggested.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Australia / Canada / Health Expenditures / Drug Approval / Delivery of Health Care / Drug and Narcotic Control / Nonprescription Drugs / European Union / Japan / Korea Country/Region as subject: North America / Asia / Oceania Language: Korean Journal: Korean Journal of Clinical Pharmacy Year: 2018 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Australia / Canada / Health Expenditures / Drug Approval / Delivery of Health Care / Drug and Narcotic Control / Nonprescription Drugs / European Union / Japan / Korea Country/Region as subject: North America / Asia / Oceania Language: Korean Journal: Korean Journal of Clinical Pharmacy Year: 2018 Type: Article